Zenith Drugs Peer Comparison

Zenith Drugs Ltd. exhibits strong profitability metrics but lacks growth and valuation appeal compared to peers. It holds promising efficiency ratios but needs to address its revenue stagnation to compete effectively. Among peers, firms like Cipla Ltd. and Mankind Pharma Ltd. show strong growth and profitability, while Sun Pharmaceutical Industries Ltd. appears overvalued despite decent operational performance.

• • Zenith Drugs Ltd. has strong ROE at 24.12% but no revenue growth.
• • Cipla Ltd. and Mankind Pharma Ltd. are standout growth performers with strong YoY revenue increases.
• • Sun Pharmaceutical Industries Ltd. is significantly overvalued with a PE of 87.59.
• • Divi's Laboratories Ltd. shows weaknesses in revenue growth despite a high EPS and ROCE.
• • Companies like Torrent Pharmaceuticals and Dr. Reddy's show solid profitability but face valuation concerns.

• • Cipla Ltd.: Strong revenue growth (13.28% YoY), solid profitability metrics, and reasonable valuation.
• • Mankind Pharma Ltd.: Exceptional revenue growth (18.12% YoY) and strong profitability ratios.
• • Dr. Reddy's Laboratories Ltd.: High profitability with a ROE of 21.76% and attractive valuation metrics.